Table 2 Results of univariate analysis of factors contributing to PVT resolution.
From: Effectiveness of edoxaban in portal vein thrombosis associated with liver cirrhosis
Variables | Category | Univariate analysis | ||
|---|---|---|---|---|
Odds ratio | 95% confidence interval | p-value | ||
Age | ≥ 65 | 0.47 | 0.11–1.91 | 0.27 |
Gender | Male | 1.55 | 0.45–5.28 | 0.49 |
Etiology | Viral hepatitis | 2.10 | 0.57–7.68 | 0.25 |
History of hepatocellular carcinoma | Yes | 1.13 | 0.30–4.30 | 0.85 |
Localization of PVT | MPV | 1.14 | 0.34–3.73 | 0.83 |
Time to start treatment | Within 1 month | 0.92 | 0.32–3.58 | 0.92 |
Drugs | Edoxaban | 5.73 | 1.10–29.78 | 0.04 |
